C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target
about
Neurovascular contributions to migraine: Moving beyond vasodilationPotential new drug treatments for congestive heart failure.Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.Inhibitory effects of C-type natriuretic peptide on the differentiation of cardiac fibroblasts, and secretion of monocyte chemoattractant protein-1 and plasminogen activator inhibitor-1.Gene expression profiling of the venom gland from the Venezuelan mapanare (Bothrops colombiensis) using expressed sequence tags (ESTs).C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure.Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney.Signal peptides: new markers in cardiovascular disease?Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway.Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level.Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.Molecular Physiology of Membrane Guanylyl Cyclase Receptors.The human endolymphatic sac expresses natriuretic peptides.Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.The multifaceted role of natriuretic peptides in metabolic syndrome.Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced ObesityThe alteration of NTproCNP plasma levels following anaerobic exercise in physically active young men.Mechanisms of Atherosclerosis: New Insights and Novel Therapeutic Approaches.Adipocyte-specific expression of C-type natriuretic peptide suppresses lipid metabolism and adipocyte hypertrophy in adipose tissues in mice fed high-fat diet.A common humoral background of intraocular and arterial blood pressure dysregulation.Increased circulating bioactive C-type natriuretic peptide is associated with reduced heart rate variability in patients with chronic kidney disease.Genome-wide association study of extreme high bone mass: Contribution of common genetic variation to extreme BMD phenotypes and potential novel BMD-associated genes
P2860
Q28392631-42DCE189-A310-42BC-B39B-BF81BAC11B52Q30251531-C3F244C8-47DA-4FE8-8F8F-251BF61B0B65Q34150487-13E61F34-40AD-48F7-B465-C07DA864C396Q34540845-47196139-EDA4-4C84-B1FD-DFE4EF72C0FEQ36654432-7AE25BFC-0129-45AA-9270-65B5B1EBD794Q36947760-BA8AEFEE-C056-4E67-A725-9073455B55DFQ37231706-A31171A3-293E-4783-B2CB-ADA85B94339EQ38262570-A2D1FCCC-CB7A-4610-A051-9244F783A9B5Q38605457-6AADB8B7-03D6-4302-808B-E2649F2EB6B3Q38667872-45261656-F822-4A56-9CFA-521BE0121701Q38750251-847FB984-48DF-48CF-9CAE-B5216FAA480EQ38794203-8E730C8B-A62A-4C52-A656-E0870DDFB65FQ38906947-D737D8FA-F00F-4B7F-A874-807CA7F19453Q39192295-2776C30B-901E-49C1-8101-6EA77CA44F13Q39362608-024957F6-7537-492E-9F0E-114CFFB40624Q41547951-03396A8F-EB64-415F-A266-CDCC8B621EE2Q42078351-0EB4E28F-6C1D-499A-BC74-7E68F533BB1FQ43146845-FBB49D61-4E93-462E-BE9B-7100717ABAB3Q48042234-AB7C3104-92C2-4124-A87D-452348A1F8C7Q50010662-9CE84B92-2DF2-476E-8EC3-2CD1BFA70F1FQ54969950-790E8BD8-DD17-4F28-BF44-0F4E1B503638Q57101451-BFE46B45-02A3-48B6-B175-C8D5BDB037EE
P2860
C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
C-type natriuretic peptide (CN ...... ential as a therapeutic target
@ast
C-type natriuretic peptide (CN ...... ential as a therapeutic target
@en
type
label
C-type natriuretic peptide (CN ...... ential as a therapeutic target
@ast
C-type natriuretic peptide (CN ...... ential as a therapeutic target
@en
prefLabel
C-type natriuretic peptide (CN ...... ential as a therapeutic target
@ast
C-type natriuretic peptide (CN ...... ential as a therapeutic target
@en
P2860
P1476
C-type natriuretic peptide (CN ...... ential as a therapeutic target
@en
P2093
Natalie G Lumsden
P2860
P304
P356
10.2174/138161210794519237
P577
2010-01-01T00:00:00Z